Differential detection of human papillomavirus (HPV) DNA types 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68 (Qualitative detection)

Rules for preparing patients for urinalysis in men

– Abstain from sexual intercourse for 3 days.
– Refrain from alcohol and spicy food for 3 days.
– Submit the material for examination before, or no earlier than 14 days after the end of the course of medical therapy (antibacterial and antifungal drugs), unless otherwise recommended by the doctor.
– Refrain from using local medications and procedures during the day.
– Immediately before taking the test, refrain from urinating for 2-3 hours.

Rules for preparing patients for a vaginal scraping in women

– Abstain from sexual intercourse for 3 days.
– Refrain from alcohol and spicy food for 3 days.
– Submit the material for examination before, or no earlier than 14 days after the end of the course of medical therapy (antibacterial and antifungal drugs), unless otherwise recommended by the doctor.
– During the day, refrain from using local dosage forms (suppositories, ointments, douches, contraceptives, etc.) and intimate hygiene products containing bactericidal additives.
– If the scraping will be performed from the urethra, do not urinate for at least 3 hours before taking the material.
– The material cannot be donated during menstruation (only 3 days after its end).

Diagnosis of human papillomavirus infection (HPV) is important for timely detection and treatment of this disease. One of the main methods for diagnosing HPV is the differential detection of human papillomavirus (HPV) DNA based on types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59. This allows you to accurately determine the type of virus and its risk of developing oncogenicity.

Human papillomaviruses (HPV) are a group of viruses that can cause warts and various types of cancer, including cervical, anal, oral, and larynx cancers. Among the many types of HPV, HPV 16 and 18 stand out in particular because they are known to be the main causes of cervical cancer.

The infectious panel for diagnosing PVI includes specialized tests that can determine the presence and type of virus in a patient's DNA samples. The main methods for diagnosing PVI include:

1. Polymerase chain reaction (PCR): This method allows for an increase in the amount of HPV DNA in a sample, making its detection more sensitive. The DNA is then separated based on its size and compared to samples of known HPV types.
2. Hybridization analysis: This method allows you to determine the presence of specific types of HPV using special molecules that “hybridize” with the corresponding DNA of the virus and isolate it.
3. DNA sequencing: This method allows not only to determine the type of HPV, but also to determine the sequence of the entire DNA of the virus. This can be useful for studying mutations and determining the degree of risk.

Differential detection of HPV DNA based on types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 allows doctors to accurately identify a patient's specific HPV type and establish their risk of oncogenicity. For example, HPV types 16 and 18 are considered high-risk for the development of cervical cancer, so patients with these HPV types may require more careful monitoring and treatment.

An infection panel can also help determine the extent of the infection and allow doctors to choose the most effective treatment method, including immunotherapy, surgery, treatment with antiviral drugs, and more.

With the differential detection of HPV DNA and the infection panel, doctors have the opportunity to provide more accurate and individualized care to patients suffering from HPV and reduce the risk of developing cancer and other complications associated with this infection. Regular diagnosis and screening is especially important for women, as HPV can lead to cervical cancer, which is a serious health threat.